摘要
给慢性四氯化碳(CC1_4)肝损害小鼠灌喂绞股蓝总皂甙(GPs),剂量为每次75mg/kg或150mg/kg(每周5次,共3周),均能明显减轻肝组织损害,与未治疗组比较差异有显著意义(P<0.05和P<0.01)。用GPs治疗的两组小鼠血清丙氨酸转氨酶(ALT)活性均较未治疗组降低,血清白蛋白含量和A/G比值较未治疗组升高。在原代培养大鼠肝细胞损伤模型上,预先用浓度为10mg/L和40mg/L的GPs处理大鼠肝细胞,肝细胞DNA合成速率分别从CC1_4损伤组的31.9%升高到67.6%(P<0.05)和82.4%(P<0.01);肝细胞培养液中ALT活性均明显低于损伤组(P<0.01)。表明GPs能减轻CC1_4诱导的小鼠慢性肝损害和离体大鼠肝细胞损伤,改善肝脏合成白蛋白的功能,保护肝细胞DNA合成。
To evaluate the hepatoprotective effect of Gypenosides ( GPs ) , the models of carbon tetrachloride (CC1_4) -induced chronic hepatic damage in mice and hepatocellular injury in primary cultured rat hepatocytes were employed . The results showed that after administering GPs to mice , either 75 mg/kg or 150 mg/kg a day , for 3 weeks , the liven damaged by CC1_4 were improved obvious- ly . The alanine transaminace ( ALT) activity decreased and albumin and A/G ratio increased in serum of GPs treated mice in comparison with controls . Meanwhile , in rat hepatocytes pretreated with GPa , the DNA synthesis rate was enhanced and the ALT activity was re- duced dose-dependently , as compared with the hepatocytes untreated with GPs . It is suggested that GPs can protect against CC1_4-in- duced damage in both mouse liver and cultured rat hepatocytes , owing to the inhibition of lipid peroxidation by GPs .
出处
《武警医学》
CAS
1998年第2期70-73,共4页
Medical Journal of the Chinese People's Armed Police Force